Clinical and paraclinical characteristics and treatment outcomes of patients with minor stroke admitted within the first 4.5 hours

Tạp chí Nghiên cứu Y học - Tập 196 Số 11E17 - Trang 59-72 - 2025
Mai Duy Ton, Ha Tran Hung, Nguyen Tien Dung

Tóm tắt

The optimal therapeutic approach for patients with minor stroke presenting within 4.5 hours of symptom onset remains a subject of ongoing debate, particularly regarding the efficacy and safety of intravenous thrombolysis with alteplase compared to single (SAPT) or dual antiplatelet therapy (DAPT). We conducted a single-center, observational cohort study involving patients with acute minor stroke (NIHSS ≤ 5) who were admitted within 4.5 hours to the Stroke Center of Bach Mai Hospital. Patients were stratified into three treatment groups: intravenous alteplase, DAPT, and SAPT. The primary outcome was a favorable functional incidence at 90 days, defined as a modified Rankin Scale (mRS) score of 0–1. The results show that among 186 patients (34 alteplase, 119 DAPT, 33 SAPT), the proportions achieving mRS 0–1 at day 90 were 90.4% (79.4%, 96.7%, and 78.8%, respectively). The alteplase group demonstrated a higher baseline NIHSS score (median 4 [IQR: 3.75 – 5]) than the DAPT and SAPT groups (both with a median of 2; p < 0.001). Early neurological deterioration (END) occurred in 38.2% of the alteplase group, 18.2% of the SAPT group, and 0.8% of the DAPT group. END was an associated factor with unfavorable outcomes (mRS 2–6), with an adjusted odds ratio of 2.14 (95% CI: 1.25 – 3.68; p < 0.01). In this single-center observational study, 90.4% of patients with minor stroke achieved favorable functional outcomes at 90th day. The rates of favorable outcomes in the DAPT, alteplase, and SAPT groups were 96.7%, 79.4%, and 78.8%, respectively. Patients treated with alteplase had higher baseline NIHSS scores and a greater frequency of early neurological deterioration, which was associated with poor functional outcomes at 90 days.

Từ khóa

#Minor stroke #thrombolysis #dual antiplatelet #single antiplatelet #first 4.5 hours

Tài liệu tham khảo

Fischer U, Baumgartner A, Arnold M, et al. What Is a Minor Stroke? Stroke. 2010;41(4):661-666. doi:10.1161/STROKEAHA.109.572883

Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I-LXII. doi:10.1177/2396987321989865

Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211

Romano JG, Gardener H, Campo-Bustillo I, et al. Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS. Stroke. 2021;52(6):1995-2004. doi:10.1161/STROKEAHA.120.032809

Sung SM, Kang YJ, Cho HJ, et al. Prediction of early neurological deterioration in acute minor ischemic stroke by machine learning algorithms. Clin Neurol Neurosurg. 2020;195:105892. doi:10.1016/j.clineuro.2020.105892

Dawson J, Béjot Y, Christensen LM, et al. European Stroke Organisation (eso) Guideline on Pharmacological Interventions for Long-Term Secondary Prevention After Ischaemic Stroke or Transient Ischaemic Attack. Eur Stroke J. 2022;7(3):I-XLI. doi:10.1177/23969873221100032

Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. doi:10.1161/STR.0000000000000375

Khatri P, Kleindorfer DO, Devlin T, et al. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018;320(2):156-166. doi:10.1001/jama.2018.8496

Chen HS, Cui Y, Zhou ZH, et al. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. JAMA. 2023;329(24):2135-2144. doi:10.1001/jama.2023.7827

Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke. J NeuroInterventional Surg. Published online March 1, 2019. doi:10.1136/neurintsurg-2018-014569

Banks JL, Marotta CA. Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials. Stroke. 2007;38(3):1091-1096. doi:10.1161/01.STR.0000258355.23810.c6

Bluhmki E, Chamorro Á, Dávalos A, et al. Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12):1095-1102. doi:10.1016/S1474-4422(09)70264-9

Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41. doi:10.1161/01.STR.24.1.35

Tu WJX Yicheng, Liu Yakun, Li Jilai, et al. Intravenous Thrombolysis or Medical Management for Minor Strokes. Thromb Haemost. 2023;123(07):734-743. doi:10.1055/s-0043-1768150

Duan C, Xiong Y, Gu HQ, et al. Outcomes in minor stroke patients treated with intravenous thrombolysis. CNS Neurosci Ther. 2023;29(8):2308-2317. doi:10.1111/cns.14164

Luo X, Huo T, Cao P, et al. Thrombolysis Versus Nonthrombolyzed in Patients With Mild Strokes and Large Vessel Occlusions: Results of a Multicenter Stroke Registration. The Neurologist. 2024;29(1):31. doi:10.1097/NRL.0000000000000516

Moawad MHED, Salem T, Alaaeldin A, et al. Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients. BMC Neurol. 2025;25(1):33. doi:10.1186/s12883-024-04000-8

Broccolini A, Brunetti V, Colò F, et al. Early neurological deterioration in patients with minor stroke due to isolated M2 occlusion undergoing medical management: a retrospective multicenter study. J NeuroInterventional Surg. 2024;16(1):38-44. doi:10.1136/jnis-2023-020118

Thông tin
Thông tin xuất bản

Tạp chí Nghiên cứu Y học

Tập 196 Số 11E17

59-72

Thông tin tác giả